✦ LIBER ✦

End points and clinical trial designs in pulmonary arterial hypertension: Clinical and regulatory perspectives

✍ Scribed by Marius M Hoeper; Ronald J Oudiz; Andrew Peacock; Victor F Tapson; Sheila G Haworth; Adaani E Frost; Adam Torbicki

Book ID: 119264060
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 120 KB
Volume: 43
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2004.02.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

End Points and Clinical Trial Design in

End Points and Clinical Trial Design in Pulmonary Arterial Hypertension

✍ Vallerie V. McLaughlin; David B. Badesch; Marion Delcroix; Thomas R. Fleming; Se 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 350 KB

Are Hemodynamics Surrogate End Points in

Are Hemodynamics Surrogate End Points in Pulmonary Arterial Hypertension?

✍ Ventetuolo, C. E.; Gabler, N. B.; Fritz, J. S.; Smith, K. A.; Palevsky, H. I.; K 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 916 KB

Clinical perspective: biomarkers in pulm

Clinical perspective: biomarkers in pulmonary arterial hypertension

✍ G. A. Heresi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

[Clinical Trials] Clinical Trials in Rhe

[Clinical Trials] Clinical Trials in Rheumatoid Arthritis and Osteoarthritis Volume 3797 || Study Design and End Points for Rheumatoid Arthritis Trials

✍ Reid, David M.; Miller, Colin G. 📂 Article 📅 2008 🏛 Springer London 🌐 English ⚖ 516 KB

Clinical trial designs: is it possible t

Clinical trial designs: is it possible to have a unified approach and common end points?

✍ Hedlund, H 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 57 KB

Progression-free survival as an end-poin

Progression-free survival as an end-point in solid tumours – Perspectives from clinical trials and clinical practice

✍ Robinson, Andrew G.; Booth, Christopher M.; Eisenhauer, Elizabeth A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 375 KB